Table 2.
Recurrent CNVs unique to polyposis patients. Note location of recurrent CNV, the type of CNV identified in each patient, description of the CNV (Chr, Start, End, size) and patient ID.
| Location | CNV Type | Chr | Start (bp) | End (bp) | Size (Kb) | Patient IDs |
|---|---|---|---|---|---|---|
| 2q34 | Gain | 2 | 209,751,678 | 209,923,081 | 171.4 | FAP6 |
| Gain* | 2 | 209,793,755 | 209,821,161 | 27.41 | FAP23 | |
| 2q32.3 | Loss | 2 | 194,626,162 | 194,695,204 | 69.04 | FAP19 |
| Loss | 2 | 194,626,162 | 194,696,112 | 69.95 | FAP20 | |
| 3q26.1 | Loss | 3 | 166,523,809 | 166,565,186 | 41.38 | FAP4 |
| Loss | 3 | 166,523,809 | 166,565,186 | 41.38 | FAP17 | |
| 4q12 | Gain | 4 | 57,745,642 | 57,794,798 | 49.16 | FAP24 |
| Gain | 4 | 57,745,642 | 57,794,798 | 49.16 | FAP4 | |
| 3q26.32 | Loss | 3 | 177,370,126 | 177,396,832 | 26.71 | FAP21 |
| Loss | 3 | 177,370,126 | 177,396,832 | 26.71 | FAP5 | |
| Loss | 3 | 177,370,126 | 177,396,832 | 26.71 | FAP22 | |
| 18p11.32 | Loss | 18 | 1,891,809 | 1,974,284 | 82.48 | FAP4 |
| Loss | 18 | 1,894,368 | 1,974,284 | 79.92 | FAP1 | |
| Loss | 18 | 1,894,368 | 1,974,284 | 79.92 | FAP2 | |
| Loss | 18 | 1,894,368 | 1,974,284 | 79.92 | FAP3 | |
| Loss | 18 | 1,964,144 | 2,015,983 | 51.84 | FAP5 |
⁎
indicates the CNVs not reported in the DGV